Biopharmaceutical stocks that have lagged behind the broader market may finally have their day in the sun. BofA Securities ...

The pharmaceutical powerhouse has two drugs that disrupt the transmission of the virus, one of which has been approved for ...

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Gilead Sciences (GILD – Research Report) today and set a price target of $140.00.

In a report released today, Tim Anderson from Bank of America Securities maintained a Buy rating on Gilead Sciences (GILD – Research Report), ...

The Latest research report offers an in-depth analysis of the Healthcare Nanotechnology Market, highlighting key trends in product segmentation, company dynamics, revenue streams, market share, recent ...

Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

DelveInsight's "XPOVIO Market Size, Forecast, and Market Insight Report" highlights the details around XPOVIO, a first-in-class, oral selective inhibitor of nuclear export (SINE) ...

Lake Travis ISD voters will elect trustees for three board seats on May 3, with a contested race for Place 3 between ...

Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, ...

With over seven years of experience in data science and analytics, Nidhi has led high-impact projects at leading healthcare ...